8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001479290-23-000017
CIK 0001479290operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:05 PM ET
Size
177.8 KB
Accession
0001479290-23-000017
Documents
- 8-Krvnc-20230131.htmPrimary
8-K
- EX-101.SCHrvnc-20230131.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABrvnc-20230131_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErvnc-20230131_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLrvnc-20230131_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001479290-23-000017-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:05 PM ET
- Size
- 177.8 KB